Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SILO stock hub

Silo Pharma, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SILOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SILO

In the news

Latest news · SILO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-74.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-47.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SILO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001514183
Company name	Silo Pharma, Inc.
Country	United States
Country code	US
Cusip	82711P102
Employees	3
Employees Change	0%
Employees Change Percent	0
Enterprise value	$-270,795
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US82711P2011
Last refreshed	2026-05-10
Market cap	$6.6M
Market cap category	Nano-Cap
Price	$0.41
Price currency	USD
Rev Per Employee	24,034x
Sector	Healthcare
Sic	2834
Symbol	SILO
Website	https://silopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-64.17%
P/B ratio	0.86x
P/S ratio	91.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	38.57%
Gross Profit	$27,807
Gross Profit Growth	-58.04%
Gross Profit Growth3 Y	-25.13%
Net Income	$-4.2M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-5,863.5%
Profit Per Employee	$-1.4M
ROA	-35.63
Roa5y	-30.05
ROCE	-61.55
ROE	-74.56
Roe5y	-31.36
ROIC	-47.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-38.22%
Cagr1y	-50.02%
Cagr3y	-43.11%
Cagr5y	-49.84%
EPS Growth Years	3
Revenue Growth Years	0x
Revenue Growth3 Y	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$7.6M
Cash	$6.9M
Current Assets	$7.4M
Current Liabilities	$650,183
Equity	$6.3M
Interest Coverage	-114.8
Liabilities	$1.3M
Long Term Assets	$217,375
Long Term Liabilities	$649,476
Net Cash	$6.9M
Net Cash By Market Cap	$104
Net Cash Growth	-3.13%
Net Debt Equity	$-1.09
Tangible Book Value	$6.1M
Tangible Book Value Per Share	$0.46
WACC	8.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.36
Net Working Capital	$-121,223
Quick ratio	10.55
Working Capital	$6.7M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-127.76%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.19%
1Y total return	-50%
200-day SMA	0.49
3Y total return	-81.59%
50-day SMA	0.41
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.82%
All Time High	125
All Time High Change	-99.68%
All Time High Date	2014-05-15
All Time Low	0.22
All Time Low Change	83.26%
All Time Low Date	2026-02-18
ATR	0.05
Beta	0.77
Beta1y	1.39
Beta2y	-0
Ch YTD	19.12
High	0.42
High52	1.13
High52 Date	2025-05-13
High52ch	-64.16%
Low	0.39
Low52	0.22
Low52 Date	2026-02-18
Low52ch	83.26%
Ma50ch	-0.78%
Premarket Change Percent	-2.38
Premarket Price	$0.41
Premarket Volume	33,261
Price vs 200-day SMA	-17.08%
RSI	44.85
RSI Monthly	37.06
RSI Weekly	46.79
Sharpe ratio	-0.01x
Sortino ratio	0.04
Total Return	-127.76%
Tr YTD	19.12
Tr1m	-23.61%
Tr1w	-10.99%
Tr3m	32.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-4.3M
Operating margin	-5,937

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,832,876%
Float Percent	97.33%
Shares Insiders	2.67%
Shares Institutions	7.86%
Shares Out	16,266,593
Shares Qo Q	43.38%
Shares Yo Y	127.76%
Short Float	0.43%
Short Ratio	0.06
Short Shares	0.41

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,960,490.75x
Bv Per Share	0.47
Ch10y	-99.19
Ch1m	-23.61
Ch1w	-10.99
Ch1y	-50
Ch3m	32.44
Ch3y	-81.59
Ch5y	-96.82
Ch6m	-12.43
Change	-3.57%
Change From Open	-1.32
Close	0.42
Days Gap	-2.29
Depreciation Amortization	11,440
Dollar Volume	154,554.1
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-4.3M
EBITDA	$-4.3M
EPS	$-0.5
F Score	1
Financing CF	4,860,219
Fiscal Year End	December
Founded	2,010
Investing CF	644,021
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Last Split Date	2022-09-15
Last Split Type	Reverse
Last10k Filing Date	2026-03-27
Ma150	0.42
Ma150ch	-4.32%
Ma20	0.47
Ma20ch	-14.56%
Net CF	842,901
Next Earnings Date	2026-05-22
Open	0.41
Optionable	No
Position In Range	46.24
Post Close	0.41
Postmarket Change Percent	1.19
Postmarket Price	$0.41
Pre Close	0.42
Price Date	2026-05-08
Ptbv Ratio	1.08
Relative Volume	0.13x
Revenue	72,102x
SBC By Revenue	881.04x
Share Based Comp	635,246
Tr6m	-12.43%
Us State	Florida
Volume	381,615
Z Score	-1.71

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SILO pay a dividend?

Capital-return profile for this ticker.

Performance

SILO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SILO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.9%

Float: +97.3% of shares outstanding

Insider ownership

+2.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SILO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.9

Neutral momentum band

Price vs 200-day MA

-17.1%

50/200-day relationship not available

Beta (5Y)

0.77

Less volatile than the market

Sharpe ratio

-0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SILO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SILO stock rating?

Silo Pharma, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SILO analysis?

The full report lives at /stocks/SILO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SILO?

The latest report frames SILO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SILO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.